Medicare Enrolled

Dr. Paul Basuk, M.D.

Gastroenterology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
310 E 72ND ST, New York, NY 10021
2128619715
In practice since 2005 (20 years)
NPI: 1033194675 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Basuk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Basuk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Basuk

Dr. Paul Basuk is a gastroenterology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Basuk performed 781 Medicare services across 633 unique beneficiaries.

Between the years covered by Open Payments, Dr. Basuk received a total of $11,233 from 43 pharmaceutical and/or device companies across 643 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Basuk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 32% volume in NY $11,233 industry payments

Medicare Practice Summary

Medicare Utilization ↗
781
Medicare services
Top 32% in NY for gastroenterology
633
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
356 $78 $350
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
78 $94 $1,600
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
69 $232 $1,750
Online digital E/M service, established patient, 21+ minutes
An online digital evaluation and management service for an established patient. This service requires a total time of 21 or more minutes over a period of up to 7 days.
62 $40 $300
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
55 $92 $1,350
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
47 $8 $35
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
41 $153 $1,500
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $49 $250
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $111 $400
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
19 $91 $550
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,233
Total received (2018-2024)
Avg $1,605/year across 7 years
Top 19% in NY for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
643
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,216 (99.9%)
Other
Charitable contributions, space rental, and other categories
$17 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,094
2023
$2,138
2022
$2,209
2021
$1,838
2020
$899
2019
$1,191
2018
$864

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$329
Janssen Biotech, Inc.
$293
Takeda Pharmaceuticals U.S.A., Inc.
$263
Merck Sharp & Dohme LLC
$244
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$201
QOL Medical, LLC
$189
PFIZER INC.
$136
Celgene Corporation
$91
Phathom Pharmaceuticals, Inc.
$79
Regeneron Healthcare Solutions, Inc.
$64
GENZYME CORPORATION
$44
Ardelyx, Inc.
$38
AIMMUNE THERAPEUTICS, INC.
$37
IRONWOOD PHARMACEUTICALS, INC
$35
Intercept Pharmaceuticals, Inc.
$31
Madrigal Pharmaceuticals
$21
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,529
Takeda Pharmaceuticals U.S.A., Inc.
$1,101
QOL Medical, LLC
$979
AbbVie Inc.
$908
ABBVIE INC.
$744
Celgene Corporation
$719
Janssen Biotech, Inc.
$639
Merck Sharp & Dohme LLC
$485
AbbVie, Inc.
$358
Ferring Pharmaceuticals Inc.
$272
Daiichi Sankyo Inc.
$247
Allergan Inc.
$230
PFIZER INC.
$202
GENZYME CORPORATION
$187
Regeneron Healthcare Solutions, Inc.
$172
Merck Sharp & Dohme Corporation
$144
Intercept Pharmaceuticals, Inc.
$118
Nestle HealthCare Nutrition Inc.
$98
Ironwood Pharmaceuticals, Inc
$87
Gilead Sciences, Inc.
$80
Phathom Pharmaceuticals, Inc.
$79
INTERCEPT PHARMACEUTICALS, INC.
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Ardelyx, Inc.
$75
Synergy Pharmaceuticals Inc
$73
Romark Laboratories, LC
$65
Endo Pharmaceuticals Inc.
$62
Boston Scientific Corporation
$43
AIMMUNE THERAPEUTICS, INC.
$37
UCB, Inc.
$37
Concordia Pharmaceuticals Inc.
$35
IRONWOOD PHARMACEUTICALS, INC
$35
Shionogi Inc
$32
Mallinckrodt Hospital Products Inc.
$30
Olympus America Inc.
$26
Braintree Laboratories, Inc.
$24
Alnylam Pharmaceuticals Inc.
$21
Madrigal Pharmaceuticals
$21
GlaxoSmithKline, LLC.
$19
FUJIFILM Healthcare Americas Corporation
$17
Alfasigma USA, Inc.
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
Cumberland Pharmaceuticals, Inc.
$15
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
ALINIA · APRISO · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CIMZIA · CLENPIQ · CREON · CYCLOSET · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · Donnatal · ENTYVIO · EVIS EXERA · Entyvio · FUJIFILM · General - EndoChoice · General - GI Dilatation · HUMIRA · Humira · IBSRELA · INJECTAFER · KRISTALOSE · LINZESS · Linzess · MOTEGRITY · Mavyret · NASCOBAL · OCALIVA · ONPATTRO · PLENVU · REMICADE · RESMETIROM · RINVOQ · SHINGRIX · SKYRIZI · STELARA · SUCRAID · SUTAB · Sucraid · Symproic · TERLIVAZ · TREMFYA · TRULANCE · Trulance · UCERIS TABLETS · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in New York?
Compare gastroenterologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
1,237
Per 100K population
76.0
County median income
$104,553
Nearest hospital
HOSPITAL FOR SPECIAL SURGERY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Basuk is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Basuk experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Basuk performed 356 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Basuk receive payments from pharmaceutical companies?
Yes. Dr. Basuk received a total of $11,233 from 43 companies across 643 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Basuk's costs compare to other gastroenterologists in New York?
Dr. Basuk's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Basuk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →